Conserved karyotypes in cophomantini: Cytogenetic analysis of 12 species from 3 species groups of bokermannohyla (Amphibia: Anura: Hylidae)

Bokermannohyla is one of the five genera included in the recently recognized tribe Cophomantini, of the hylid frog subfamily Hylinae. Although karyotypic diversity is relatively well known in two genera of Cophomantini, Aplastodiscus and Hypsiboas, in Bokermannohyla chromosome data are restricted to only two of its 28 species. In this paper, we describe the karyotypes of 12 species of Bokermannohyla using standard staining, Ag-NOR, C-banding, DAPI, CMA3, and BrdU incorporation. The 12 species share a similar diploid karyotype with 2n ?=? 24 biarmed chromosomes; most observed differences involved the NOR-bearing chromosomes (and the NOR position within these chromosomes) and C-banding patterns. The overall similarity of these karyotypes with those of Aplastodiscus and Hypsiboas widens the notion of remarkable morphological homogeneity among Cophomantini karyotypes. The results obtained thus far are promising for comparative studies on the genus Bokermannohyla and, in a wider sense, will allow a better understanding of karyotype differentiation and chromosomal evolution in Cophomantini.Fil: Catroli, Glaucilene Ferreira. Universidade Estadual Paulista Julio de Mesquita Filho; BrasilFil: Faivovich, Julián. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales “Bernardino Rivadavia”; ArgentinaFil: Haddad, Célio F. B.. Universidade Estadual Paulista Julio de Mesquita Filho; BrasilFil: Kasahara, Sanae. Universidade Estadual Paulista Julio de Mesquita Filho; Brasi

Karyotypic Data on 28 Species of Scinax (Amphibia: Anura: Hylidae): Diversity and Informative Variation

The hylid frog genus Scinax is the most species-rich within Hylinae, with more than 100 recognized species grouped in the S. catharinae and S. ruber clades. The karyotypes of 14 species of the S. catharinae clade and 14 of the S. ruber clade were analyzed, several of them for the first time. All studied species presented 2n = 2x = 24 biarmed chromosomes (FN = 48) and no identifiable sex chromosomes. There are two alternate states associated with the size and morphology of pair 1, corresponding to the S. catharinae clade and to the S. ruber clade. The morphology of pairs 2 and 6 also differentiate the species of both major clades. Species of the S. ruber clade in general have Ag-NORs in pair 11, as is commonly observed among hylines with 2n = 24. The Ag-NORs' position in the long arms of pair 11 is interstitial in S. fuscomarginatus, S. fuscovarius, S. nasicus, S. similis, S. squalirostris, and S. uruguayus, and terminal in S. acuminatus, S. curicica, S. duartel, S. granulatus, S. hayii, and S. perereca. The single exception among species of the S. ruber clade is S. alter, which has terminal Ag-NORs at the long arms of pair 3. Most species of the S. catharinae clade have Ag-NORs in pair 6, representing a putative synapomorphy of this clade, while the Ag-NORs in pair 11 that occur in S. canastrensis are most parsimoniously interpreted as a reversion. C-banding is predominantly centromeric, but in the S. catharinae clade there is a greater amount of heterochromatin than in the S. ruber clade. This study corroborates the occurrence of informative variation, some already considered in a previous cladistic analysis, and reports new characters, outlining the significance of cytogenetic data for the systematics of Scinax.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP

Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice.

Current treatments for chronic pain rely largely on opioids despite their substantial side effects and risk of addiction. Genetic studies have identified in humans key targets pivotal to nociceptive processing. In particular, a hereditary loss-of-function mutation in NaV1.7, a sodium channel protein associated with signaling in nociceptive sensory afferents, leads to insensitivity to pain without other neurodevelopmental alterations. However, the high sequence and structural similarity between NaV subtypes has frustrated efforts to develop selective inhibitors. Here, we investigated targeted epigenetic repression of NaV1.7 in primary afferents via epigenome engineering approaches based on clustered regularly interspaced short palindromic repeats (CRISPR)-dCas9 and zinc finger proteins at the spinal level as a potential treatment for chronic pain. Toward this end, we first optimized the efficiency of NaV1.7 repression in vitro in Neuro2A cells and then, by the lumbar intrathecal route, delivered both epigenome engineering platforms via adeno-associated viruses (AAVs) to assess their effects in three mouse models of pain: carrageenan-induced inflammatory pain, paclitaxel-induced neuropathic pain, and BzATP-induced pain. Our results show effective repression of NaV1.7 in lumbar dorsal root ganglia, reduced thermal hyperalgesia in the inflammatory state, decreased tactile allodynia in the neuropathic state, and no changes in normal motor function in mice. We anticipate that this long-lasting analgesia via targeted in vivo epigenetic repression of NaV1.7 methodology we dub pain LATER, might have therapeutic potential in management of persistent pain states

Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain.

Neuroinflammation is a major component in the transition to and perpetuation of neuropathic pain states. Spinal neuroinflammation involves activation of TLR4, localized to enlarged, cholesterol-enriched lipid rafts, designated here as inflammarafts. Conditional deletion of cholesterol transporters ABCA1 and ABCG1 in microglia, leading to inflammaraft formation, induced tactile allodynia in naive mice. The apoA-I binding protein (AIBP) facilitated cholesterol depletion from inflammarafts and reversed neuropathic pain in a model of chemotherapy-induced peripheral neuropathy (CIPN) in wild-type mice, but AIBP failed to reverse allodynia in mice with ABCA1/ABCG1-deficient microglia, suggesting a cholesterol-dependent mechanism. An AIBP mutant lacking the TLR4-binding domain did not bind microglia or reverse CIPN allodynia. The long-lasting therapeutic effect of a single AIBP dose in CIPN was associated with anti-inflammatory and cholesterol metabolism reprogramming and reduced accumulation of lipid droplets in microglia. These results suggest a cholesterol-driven mechanism of regulation of neuropathic pain by controlling the TLR4 inflammarafts and gene expression program in microglia and blocking the perpetuation of neuroinflammation